| Bilal Harake, MD | |
|
2425 Bath St, Santa Barbara, CA 93105-4324 | |
| (805) 569-3146 | |
| (805) 569-0786 |
| Full Name | Bilal Harake |
|---|---|
| Gender | Male |
| Speciality | Pediatrics - Pediatric Cardiology |
| Location | 2425 Bath St, Santa Barbara, California |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1215017223 | NPI | - | NPPES |
| 00A444451 | Medicaid | CA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2080P0202X | Pediatrics - Pediatric Cardiology | A44445 (California) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Bilal Harake, MD Po Box 1359, San Clemente, CA 92674-1359 Ph: (949) 492-3514 | Bilal Harake, MD 2425 Bath St, Santa Barbara, CA 93105-4324 Ph: (805) 569-3146 |
News Archive
A new study discusses variations in viral pathogenicity and in transmission, which are responsible for asymptomatic infection and for superspreading events. The ability to understand this would open the way to understand how this virus behaves the way it does, in terms of its virulence, its spread, and its emergent variants of concern.
Celldex Therapeutics, Inc. today announced the results of a positive Phase 2 study of CDX-011 (formerly CR011-vcMMAE), in patients with heavily pre-treated, locally advanced or metastatic breast cancers.
Leading medical experts from throughout the UK will be gathering in Edinburgh today and tomorrow (21-22 April 2004) to arrive at a consensus on how best to treat and manage the 'silent epidemic' of hepatitis C - a virus which is estimated to be carried by over 400,000 people in the UK and which continues to spread globally, as the majority of carriers do not realise they have been infected.
A flexible, biodegradable optical fiber that can deliver light into the body for medical applications is the latest work of a collaboration between electrical engineers and biomaterials engineers in Penn State's Materials Research Institute.
A single infusion of an experimental anti-HIV antibody called 3BNC117 resulted in significantly decreased HIV levels that persisted for as long as 28 days in HIV-infected individuals, according to Phase 1 clinical trial findings published online today in Nature.
› Verified 5 days ago
Dr. Jenna Eve Holmen, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 400 W Pueblo St, Santa Barbara, CA 93105 Phone: 805-682-7111 | |
Patricia L Erbe, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 15 E Arrellaga St, Santa Barbara, CA 93101 Phone: 805-965-1095 Fax: 805-965-8905 | |
Cristina Santos Candido-vitto, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 427 W Pueblo St, Suite C, Santa Barbara, CA 93105 Phone: 805-569-7850 Fax: 805-682-1618 | |
David A Medina, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 15 E Arrellaga St, Santa Barbara, CA 93101 Phone: 805-965-1095 Fax: 805-965-8905 | |
Barbara J Donnelly, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: Pueblo At Bath Streets, Santa Barbara, CA 93102 Phone: 805-569-7510 Fax: 949-366-2390 | |
Augusto Julian Castaneda, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 601 E Arrellaga St, Suite 205, Santa Barbara, CA 93103 Phone: 805-963-4959 Fax: 805-963-0332 | |
Charish L Barry, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 510 W Pueblo St, Santa Barbara, CA 93105 Phone: 805-845-1221 Fax: 805-845-1224 |